Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy

European Heart Journal - Cardiovascular Imaging

6 July 2022
Organised by: Logo
ESC Journals

Abstract

AbstractAims

Right ventricular systolic dysfunction (RVSD) is an important determinant of outcomes in heart failure (HF) cohorts. While the quantitative assessment of RV function is challenging using 2D-echocardiography, cardiac magnetic resonance (CMR) is the gold standard with its high spatial resolution and precise anatomical definition. We sought to investigate the prognostic value of CMR-derived RV systolic function in a large cohort of HF with reduced ejection fraction (HFrEF).

Methods and results

Study cohort comprised of patients enrolled in the CarDiac MagnEtic Resonance for Primary Prevention Implantable CardioVerter DefibrillAtor ThErapy registry who had HFrEF and had simultaneous baseline CMR and echocardiography (n = 2449). RVSD was defined as RV ejection fraction (RVEF) <45%. Kaplan–Meier curves and cox regression were used to investigate the association between RVSD and all-cause mortality (ACM). Mean age was 59.8 ± 14.0 years, 42.0% were female, and mean left ventricular ejection fraction (LVEF) was 34.0 ± 10.8. Median follow-up was 959 days (interquartile range: 560–1590). RVSD was present in 936 (38.2%) and was an independent predictor of ACM (adjusted hazard ratio = 1.44; 95% CI [1.09–1.91]; P = 0.01). On subgroup analyses, the prognostic value of RVSD was more pronounced in NYHA I/II than in NYHA III/IV, in LVEF <35% than in LVEF ≥35%, and in patients with renal dysfunction when compared to those with normal renal function.

Conclusion

RV systolic dysfunction is an independent predictor of ACM in HFrEF, with a more pronounced prognostic value in select subgroups, likely reflecting the importance of RVSD in the early stages of HF progression.

Contributors

Andrea Barison
Andrea Barison

Author

Toscana Gabriele Monasterio Foundation Pisa , Italy

Edoardo Conte
Edoardo Conte

Author

Galeazzi-Sant'Ambrogio Hospital IRCCS Milan , Italy

Davide Margonato
Davide Margonato

Author

San Raffaele Hospital Milan , Italy

Anne Giulia Pavon
Anne Giulia Pavon

Author

Cardiocentro Ticino Institute Lugano , Switzerland

Gianluca Pontone
Gianluca Pontone

Author

Monzino Cardiology Centre Milan , Italy

ESC 365 is supported by